Fight against brain tumor will result in greater awareness and positive outcomes

NewsGuard 100/100 Score

With this morning's passing of Massachusetts Senator Ted Kennedy from a brain tumor, Wilmington's Christopher Grundner says he feels that it could lead to quicker diagnoses for others affected by the disease and more support for the cause.

In 2005, Grundner established The Kelly Heinz-Grundner Brain Tumor Foundation (KHG) after his wife, Kelly, died from this disease. He left his position as Senior Vice President at JPMorgan Chase to dedicate his life to raising awareness of brain tumors with the goal of bringing the national spotlight to brain tumors and helping people to get diagnosed faster.

Over the last four years, Grundner has raised almost $1 million and has launched a national movement called "Get Your Head In The Game," which is aimed at educating the public and medical professionals about the facts, symptoms and proper diagnosis techniques.

"Sen. Kennedy's valiant fight against this disease gives everyone serving the brain tumor community some hope that it will lead to greater awareness of brain tumors and, with this, potentially some positive outcomes, including people getting diagnosed faster and more people joining the fight," Grundner says. "This cause is where breast cancer was 25 years ago and there is a lot of work still to do."

Source: http://www.khgfoundation.org

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
AI-driven model identifies potent cancer-killing immune cells for personalized immunotherapy